Table 3. Evidence-based statements about ASCUS cytology management.
(a) | HR HPV-DNA testing is the most effective strategy (AI). |
(b) | HR HPV-DNA testing is cost-effective (AI). |
(c) | HC2 is the most widely validated test (AI). |
(d) | HC2 - negative patients can be referred to screening (BII). |
HC2: Hybrid Capture 2 |